Drug-eluting, bare metal stents pose nearly same risk of thrombosis

06/21/2011 | TheHeart.org (Montreal) (free registration)

Reporting final three-year results of the HORIZONS AMI trial in the journal The Lancet, lead researcher Dr. Gregg Stone of Columbia University Medical Center in New York said drug-eluting stents were found to be equally as safe as bare-metal stents long-term when it comes to stent thrombosis. Rates of thrombosis for both types of stents were nearly 5%, which Stone called "very concerning."

View Full Article in:

TheHeart.org (Montreal) (free registration)